Literature DB >> 2673114

Facilitation of noradrenaline release by isoprenaline is not mediated by angiotensin II in mouse atria and rat tail artery.

M A Rajanayagam1, I F Musgrave, M J Rand, H Majewski.   

Abstract

The hypothesis that facilitation of noradrenaline release by prejunctional beta-adrenoceptors is linked to the local generation of angiotensin II was investigated in rat tail artery and mouse atria which were incubated with [3H]-noradrenaline. The outflow of radioactivity induced by electrical field stimulation of the tissues was taken as an index of noradrenaline release. In mouse atria, angiotensin II (0.01 microM) enhanced the stimulation-induced (S-I) noradrenaline release and this was blocked by saralasin (0.1 microM). Isoprenaline (0.01 microM) also enhanced the S-I release of noradrenaline, but this was not blocked by either saralasin (0.1 microM and 0.3 microM) or captopril (5 microM). Furthermore, the facilitatory effects of angiotensin II (0.1 microM) and isoprenaline (0.1 microM) were additive. In rat tail artery, the facilitatory effect of angiotensin II (0.01 microM) on noradrenaline release was blocked by saralasin (0.1 microM). The facilitatory effect of isoprenaline (0.1 microM) was blocked by propranolol (1 microM) but not by saralasin (0.1 microM) nor captopril (5 microM). These results indicate that beta-adrenoceptor-mediated facilitation of noradrenaline release occurs independently of angiotensin II in mouse atria and rat tail artery.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2673114

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  5 in total

1.  Enhancement of noradrenaline release by angiotensin II and bradykinin in mouse atria: evidence for cross-talk between G(q/11) protein- and G(i/o) protein-coupled receptors.

Authors:  S L Cox; V Schelb; A U Trendelenburg; K Starke
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues.

Authors:  S L Cox; A U Trendelenburg; K Starke
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

3.  Modulation of (3)H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and beta-adrenoceptors in mouse tissues.

Authors:  A U Trendelenburg; S L Cox; V Schelb; W Klebroff; L Khairallah; K Starke
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

4.  Facilitation by procaterol, a beta-adrenoceptor agonist, of noradrenaline release in the pithed rat independently of angiotensin II formation.

Authors:  P Kotsonis; H Majewski
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

5.  Attenuation of vasoconstriction by endogenous nitric oxide in rat caudal artery.

Authors:  P A Vo; J J Reid; M J Rand
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.